Neuromyelitis optica IgG causes placental inflammation and fetal death.

Neuromyelitis optica IgG causes placental inflammation and fetal death.

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the CNS and affects women of childbearing age. Most patients with NMO have circulating Abs, termed NMO-IgG, against the astrocytic water channel protein aquaporin-4. In the CNS, NMO-IgG causes complement-mediated astrocyte damage...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Saadoun, S, Waters, P, Leite, M, Bennett, J, Vincent, A, Papadopoulos, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
ανά: Saadoun, S, κ.ά.
Έκδοση: (2013)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
ανά: Saadoun, S, κ.ά.
Έκδοση: (2013)

NMO-IgG in the diagnosis of neuromyelitis optica.
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
ανά: Saadoun, S, κ.ά.
Έκδοση: (2010)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
ανά: Akman-Demir, G, κ.ά.
Έκδοση: (2008)

Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults
ανά: J Gordon Millichap
Έκδοση: (2008-02-01)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
ανά: Kim, S, κ.ά.
Έκδοση: (2011)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
ανά: Jacob, S, κ.ά.
Έκδοση: (2008)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
ανά: Littleton, E, κ.ά.
Έκδοση: (2006)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
ανά: Narayanan Unni, κ.ά.
Έκδοση: (2013-01-01)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
ανά: Min, J, κ.ά.
Έκδοση: (2010)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
ανά: Jacob, S, κ.ά.
Έκδοση: (2007)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders
ανά: Shiyu Gao, κ.ά.
Έκδοση: (2024-03-01)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
ανά: Saadoun, S, κ.ά.
Έκδοση: (2012)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.
ανά: Saadoun, S, κ.ά.
Έκδοση: (2012)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
ανά: Tarso Adoni, κ.ά.
Έκδοση: (2008-06-01)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
ανά: Lukmanee Tradtrantip, κ.ά.
Έκδοση: (2021-11-01)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
ανά: Tianjiao Duan, κ.ά.
Έκδοση: (2018-10-01)

Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
ανά: Eun Bin Cho, κ.ά.
Έκδοση: (2024-03-01)

Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks
ανά: Edouard Januel, κ.ά.
Έκδοση: (2024-01-01)

Dried blood spot improves global access to aquaporin‐4‐IgG testing for neuromyelitis optica
ανά: Nisa Vorasoot, κ.ά.
Έκδοση: (2024-11-01)

CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
ανά: Lukmanee Tradtrantip, κ.ά.
Έκδοση: (2019-03-01)

Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
ανά: Oliver Schmetzer, κ.ά.
Έκδοση: (2021-03-01)

Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis
ανά: Li Xu, κ.ά.

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder
ανά: Zhichao Li, κ.ά.
Έκδοση: (2023-01-01)

Orbital Ectopic Lymphoid Follicles with Germinal Centers in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
ανά: Koon Ho Chan, κ.ά.
Έκδοση: (2018-01-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
ανά: Waters, P, κ.ά.
Έκδοση: (2015)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
ανά: Papadopoulos, M, κ.ά.
Έκδοση: (2011)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
ανά: Tianjiao Duan, κ.ά.
Έκδοση: (2019-07-01)

Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
ανά: Alvaro Cobo-Calvo, κ.ά.
Έκδοση: (2020-01-01)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
ανά: Jacob, A, κ.ά.
Έκδοση: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
ανά: Viegas, S, κ.ά.
Έκδοση: (2009)

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
ανά: Saadoun, S, κ.ά.
Έκδοση: (2011)

Complement activation in patients with neuromyelitis optica
ανά: Nytrova, P, κ.ά.
Έκδοση: (2014)

Complement activation in patients with neuromyelitis optica.
ανά: Nytrova, P, κ.ά.
Έκδοση: (2014)

IgG Placental Transfer in Healthy and Pathological Pregnancies
ανά: Patricia Palmeira, κ.ά.
Έκδοση: (2012-01-01)

Use of mitoxantrone in neuromyelitis optica.
ανά: Kitley, J, κ.ά.
Έκδοση: (2011)